Morphological Analysis of the Pineal Gland in Pediatric Retinoblastoma Patients Using Magnetic Resonance Imaging

MRI is useful for diagnosing pinealoblastoma in retinoblastoma patients

Completed

Looking for future studies?

Key information

Conditions

Retinoblastoma Brain Diseases Brain Neoplasms Central Nervous System Diseases Central Nervous System Neoplasms Eye Diseases Eye Diseases, Hereditary Eye Neoplasms Neoplasms Neoplasms by Histologic Type Neoplasms by Site Neoplasms, Germ Cell and Embryonal Neoplasms, Glandular and Epithelial Neoplasms, Nerve Tissue Neoplasms, Neuroepithelial Nervous System Diseases Nervous System Neoplasms Neuroectodermal Tumors Pinealoma Pineoblastoma Retinal Diseases Retinal Neoplasms

Age range

1 day–50 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Charite Hospital Berlin

Berlin, State of Berlin, 12200, Germany

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

diagnosis of retinoblastoma
brain MRI available

Exclusion criteria

insufficient quality of brain MRI

Treatment and study plan

Primary outcomes

Malignancy criteria of pineal gland

Time frame: clinical follow-up 1-year after baseline imaging

size of pineal gland solid or cystic component (all at baseline)

Sponsors and collaborators

Lead sponsor

Charite University, Berlin, Germany

Other

Registry information

Important dates

Study start: 2013
Primary completion: 2014
Study completion: 2015
First posted: Jun 21, 2013
Registry last updated: Dec 29, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed